Mobile Menu

Search Results

Search results for: drug discovery

Solving the Problem of Deconvolution Using CRISPR-Cas9

A recent article, published in Nature Communications, has outlined a new method of deconvolution using CRISPR-Cas9 for phenotypically discovered antibody […]

Using a knowledge graph to discover adverse reactions

Researchers have constructed a tumour-biomarker knowledge graph and used it to discover potential adverse drug reactions from antitumour drugs. Adverse […]

Applying AI to extend human longevity

Deep longevity, a biotech company that aims to transform longevity R&D through AI, has released a paper in Nature Ageing, […]

AI and automation across the pharmacovigilance lifecycle

Despite technological advancements within data capture, storage, linking and analysis, little attention has been paid to the impact of these […]

New artificial intelligence study of Alzheimer’s

The National Institutes of Health (NIH) have funded a five-year effort to use state-of-the-art artificial intelligence methods to study Alzheimer’s […]

Digital transformation: A Novartis review

With the end goal of reimaging global drug development, Novartis several years ago positioned themselves to “Go Big on Data” […]

Immunai secures $20M in seed funding to map immune system using ML

Immunai, a biotech start-up founded by MIT, Harvard and Stanford researchers, has emerged from stealth mode with $20 million in […]

Opinion: Why AI won’t save the pharmaceutical industry

AI won’t be the much-prophesised saving grace that rescues the pharmaceutical industry from existential decline argues Drew Smith, in a […]

Breaking Eroom’s law

Moore’s law, the expectation that as computer speed and capabilities double every few years their cost should be halved, has […]